FilingSEC EDGAR6-K
Galmed Pharmaceuticals Rebrands to Eocene and Changes Ticker to EOCN
· SEC accepted
StageOngoing
Filing content
Galmed Pharmaceuticals announced its rebranding to Eocene Ltd. and a change in its Nasdaq trading symbol to EOCN to reflect its strategic focus on gastrointestinal innovation.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…